Title: Warfarin resistance due to VKORC1 gene mutation in a patient following mechanical aortic valve replacement with an ON-X valve.
Journal: International journal of cardiology20150601
Title: Systems pharmacological analysis of drugs inducing stevens-johnson syndrome and toxic epidermal necrolysis.
Journal: Chemical research in toxicology20150518
Title: Overview of the new oral anticoagulants: opportunities and challenges.
Journal: Arteriosclerosis, thrombosis, and vascular biology20150501
Title: The role of factor Xa inhibitors in venous thromboembolism treatment.
Journal: Vascular health and risk management20150101
Title: Pharmacology of the new target-specific oral anticoagulants.
Journal: Journal of thrombosis and thrombolysis20130801
Title: Low molecular weight dual inhibitors of factor Xa and fibrinogen binding to GPIIb/IIIa with highly overlapped pharmacophores.
Journal: European journal of medicinal chemistry20130601
Title: A specific antidote for reversal of anticoagulation by direct and indirect inhibitors of coagulation factor Xa.
Journal: Nature medicine20130401
Title: Repeated bleeding complications during therapy with vitamin K antagonists in a patient with the VKORC1*2A and the CYP2C9*3/*3 alleles: genetic testing to support switching to new oral anticoagulants.
Journal: Thrombosis research20130301
Title: New anticoagulants for treatment of venous thromboembolism.
Journal: European journal of internal medicine20121201
Title: Effect of the factor Xa inhibitor rivaroxaban on arterial thrombosis in wild-type and apolipoprotein E-deficient mice.
Journal: Thrombosis research20121101
Title: Initiation of rivaroxaban following low molecular weight heparin for thromboprophylaxis after total joint replacement: the Safe, Simple Transitions (SST) study.
Journal: Thrombosis research20121101
Title: Analysis of the projected utility of dabigatran, rivaroxaban, and apixaban and their future impact on existing Hematology and Cardiology Anticoagulation Clinics at The Johns Hopkins Hospital.
Journal: Journal of thrombosis and thrombolysis20121101
Title: The in vitro anticoagulant effect of rivaroxaban in children.
Journal: Thrombosis research20121101
Title: Effects on routine coagulation screens and assessment of anticoagulant intensity in patients taking oral dabigatran or rivaroxaban: guidance from the British Committee for Standards in Haematology.
Journal: British journal of haematology20121101
Title: Interpretation of endpoints in a network meta-analysis of new oral anticoagulants following total hip or total knee replacement surgery.
Journal: Thrombosis and haemostasis20121101
Title: Management consensus guidance for the use of rivaroxaban--an oral, direct factor Xa inhibitor.
Journal: Thrombosis and haemostasis20121101
Title: Plasma factor Xa inhibition can predict antithrombotic effects of oral direct factor Xa inhibitors in rabbit atherothrombosis models.
Journal: Thrombosis and haemostasis20121101
Title: The effects of rivaroxaban on the complications of surgery after total hip or knee replacement: results from the RECORD programme.
Journal: The Journal of bone and joint surgery. British volume20121101
Title: [New anticoagulants - direct factor Xa-inhibitors].
Journal: Therapeutische Umschau. Revue therapeutique20121101
Title: [Laboratory diagnostic with regard to new anticoagulants - monitoring and influence on coagulation tests].
Journal: Therapeutische Umschau. Revue therapeutique20121101
Title: [Clinical pharmacological aspects of new oral anticoagulants].
Journal: Therapeutische Umschau. Revue therapeutique20121101
Title: How I treat anticoagulated patients undergoing an elective procedure or surgery.
Journal: Blood20121011
Title: Oral thromboprophylaxis in pelvic trauma: a standardized protocol.
Journal: The Journal of emergency medicine20121001
Title: For people with non-valvular atrial fibrillation rivaroxaban is non-inferior to warfarin for preventing stroke or embolism, with no difference in the risk of clinically relevant bleeding.
Journal: Evidence-based medicine20121001
Title: Effects on platelet function of a direct acting antagonist of coagulation factor Xa.
Journal: Journal of thrombosis and thrombolysis20121001
Title: Prevention of stroke in patients with atrial fibrillation: anticoagulant and antiplatelet options.
Journal: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing20121001
Title: Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.
Journal: PharmacoEconomics20121001
Title: Adjusted indirect comparison of new oral anticoagulants for stroke prevention in atrial fibrillation.
Journal: QJM : monthly journal of the Association of Physicians20121001
Title: Determination of the anti-F10a or anti-F2a generation action of rivaroxaban or dabigatran.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis20121001
Title: Anticoagulants in atrial fibrillation patients with chronic kidney disease.
Journal: Nature reviews. Nephrology20121001
Title: Anticoagulant treatment of pulmonary embolism: impact and implications of the EINSTEIN PE study.
Journal: European journal of haematology20121001
Title: Efficacy and safety of rivaroxaban or fondaparinux thromboprophylaxis in major orthopedic surgery: findings from the ORTHO-TEP registry.
Journal: Journal of thrombosis and haemostasis : JTH20121001
Title: Atrial fibrillation in long term care.
Journal: Journal of the American Medical Directors Association20121001
Title: Dabigatran versus rivaroxaban for the prevention of stroke and systemic embolism in atrial fibrillation in Canada. Comparative efficacy and cost-effectiveness.
Journal: Thrombosis and haemostasis20121001
Title: New anticoagulants for stroke prophylaxis in atrial fibrillation: assessing the impact on medication adherence.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions20121001
Title: New anticoagulants: A concise review.
Journal: The journal of trauma and acute care surgery20121001
Title: [Prophylaxis of thromboembolic events following hip and knee replacement: dabigatran, rivaroxaban or apixaban in comparison to enoxaparin].
Journal: Der Unfallchirurg20121001
Title: What did we learn from new oral anticoagulant treatment?
Journal: Thrombosis research20121001
Title: Antithrombotic treatment of atrial fibrillation: new insights.
Journal: Thrombosis research20121001
Title: Do new oral anticoagulants require laboratory monitoring? The clinician point of view.
Journal: Thrombosis research20121001
Title: Measuring Rivaroxaban in a clinical laboratory setting, using common coagulation assays, Xa inhibition and thrombin generation.
Journal: Clinical chemistry and laboratory medicine20121001
Title: The new oral anticoagulants and the future of haemostasis laboratory testing.
Journal: Biochemia medica20121001
Title: Rivaroxaban in acute coronary syndromes and atrial fibrillation: rivaroxaban shown to reduce cardiovascular deaths in STEMI patients.
Journal: Cardiovascular journal of Africa20121001
Title: Oral direct factor Xa inhibitors.
Journal: Circulation research20120928
Title: ACP Journal Club. Review: new oral anticoagulants reduced stroke and systemic embolism compared with warfarin in AF.
Journal: Annals of internal medicine20120918
Title: Cost-effectiveness of rivaroxaban compared to warfarin for stroke prevention in atrial fibrillation.
Journal: The American journal of cardiology20120915
Title: New oral anticoagulants: a review of the literature with particular emphasis on patients with impaired renal function.
Journal: Drugs20120910
Title: Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.
Journal: Journal of cardiovascular pharmacology and therapeutics20120901
Title: Novel oral anticoagulation in management of venous thromboembolism, atrial fibrillation, and acute coronary syndrome.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis20120901
Title: Antithrombotic options for atrial fibrillation in 2012.
Journal: Cardiovascular & hematological disorders drug targets20120901
Title: Efficacy of tranexamic acid on blood loss after primary cementless total hip replacement with rivaroxaban thromboprophylaxis: A case-control study in 70 patients.
Journal: Orthopaedics & traumatology, surgery & research : OTSR20120901
Title: Treatment of venous thromboembolism with dabigatran.
Journal: Current opinion in pulmonary medicine20120901
Title: Anticoagulants for the treatment of acute coronary syndrome in the era of new oral agents.
Journal: Coronary artery disease20120901
Title: The management of antithrombotic medication in skin surgery.
Journal: Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]20120901
Title: An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Journal: Thrombosis and haemostasis20120901
Title: [The ROCKET AF study].
Journal: Giornale italiano di cardiologia (2006)20120901
Title: Letter to the Editor regarding 'effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma'.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis20120901
Title: Newer oral anticoagulants: a review of laboratory monitoring options and reversal agents in the hemorrhagic patient.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20120901
Title: Systematic review and adjusted indirect comparison meta-analysis of oral anticoagulants in atrial fibrillation.
Journal: Circulation. Cardiovascular quality and outcomes20120901
Title: The novel oral anticoagulants: an update for the interventional radiologist.
Journal: AJR. American journal of roentgenology20120901
Title: [The new anticoagulants - their role in secondary prevention of thromboembolism after stroke].
Journal: Therapeutische Umschau. Revue therapeutique20120901
Title: Drug interactions with rivaroxaban following total joint replacement surgery.
Journal: The Annals of pharmacotherapy20120901
Title: The promise of novel direct oral anticoagulants.
Journal: Best practice & research. Clinical haematology20120901
Title: Advances in the management of venous thromboembolism.
Journal: Best practice & research. Clinical haematology20120901
Title: Apixaban. After hip or knee replacement: LMWH remains the standard treatment.
Journal: Prescrire international20120901
Title: Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Journal: Journal of the American College of Cardiology20120821
Title: Danger ahead: watch out for indirect comparisons!
Journal: Journal of the American College of Cardiology20120821
Title: ACP Journal Club: review: factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement.
Journal: Annals of internal medicine20120821
Title: ACP Journal Club: rivaroxaban and usual care had similar rates of recurrent VTE and bleeding in symptomatic PE.
Journal: Annals of internal medicine20120821
Title: Concomitant use of medication with antiplatelet effects in patients receiving either rivaroxaban or enoxaparin after total hip or knee arthroplasty.
Journal: Thrombosis research20120801
Title: A new era of antithrombotic therapy in patients with atrial fibrillation.
Journal: The American journal of the medical sciences20120801
Title: Dabigatran, rivaroxaban and apixaban versus enoxaparin for thomboprophylaxis after total knee or hip arthroplasty: pool-analysis of phase III randomized clinical trials.
Journal: Thrombosis research20120801
Title: Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
Journal: The American journal of cardiology20120801
Title: Novel anticoagulants for non-valvular atrial fibrillation.
Journal: Heart, lung & circulation20120801
Title: Novel oral anticoagulants in the treatment of acute coronary syndromes: is there any room for new anticoagulants?
Journal: Current clinical pharmacology20120801
Title: Oral IIa and Xa inhibitors for prevention of stroke in atrial fibrillation: clinical studies and regulatory considerations.
Journal: Current clinical pharmacology20120801
Title: Prevention and treatment of venous thromboembolism and pulmonary embolism: the role of novel oral anticoagulants.
Journal: Current clinical pharmacology20120801
Title: Breakthroughs in anticoagulation: advent of the oral direct factor Xa inhibitors.
Journal: Journal of cardiothoracic and vascular anesthesia20120801
Title: Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban: a randomised crossover ex vivo study in healthy volunteers.
Journal: Thrombosis and haemostasis20120801
Title: Anticoagulation-related intracranial hemorrhages.
Journal: Current atherosclerosis reports20120801
Title: Reverse engineering for new oral anticoagulants: non-specific reversal agents and the anticoagulant activity of dabigatran and rivaroxaban.
Journal: Thrombosis and haemostasis20120801
Title: Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Journal: International angiology : a journal of the International Union of Angiology20120801
Title: Is rivaroxaban safer and more effective than warfarin in patients with atrial fibrillation and stroke or TIA?
Journal: The Lancet. Neurology20120801
Title: [New oral anticoagulants for the prevention of stroke. Open questions in geriatric patients].
Journal: Zeitschrift fur Gerontologie und Geriatrie20120801
Title: Emerging oral anticoagulants for stroke prevention in patients with non-valvular atrial fibrillation.
Journal: Minerva cardioangiologica20120801
Title: Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial.
Journal: Expert review of cardiovascular therapy20120801
Title: Periprocedural anticoagulant management.
Journal: Hospital practice (1995)20120801
Title: The new oral anticoagulants: a challenge for hospital formularies.
Journal: Hospital practice (1995)20120801
Title: New oral anticoagulants for atrial fibrillation.
Journal: Circulation20120703
Title: Renal profiles of anticoagulants.
Journal: Journal of clinical pharmacology20120701
Title: Population pharmacokinetics and pharmacodynamics of rivaroxaban in patients with acute coronary syndromes.
Journal: British journal of clinical pharmacology20120701
Title: Pharmacologic and nonpharmacologic therapies for stroke prevention in nonvalvular atrial fibrillation.
Journal: Pacing and clinical electrophysiology : PACE20120701
Title: Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombin.
Journal: Thrombosis and haemostasis20120701
Title: Pharmacokinetic evaluation of rivaroxaban for the treatment of acute coronary syndromes.
Journal: Expert opinion on drug metabolism & toxicology20120701
Title: New drugs 2012, part 2.
Journal: Nursing20120701
Title: Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
Journal: Circulation. Cardiovascular quality and outcomes20120701
Title: Rivaroxaban for stroke prevention in atrial fibrillation and secondary prevention in patients with a recent acute coronary syndrome.
Journal: Future cardiology20120701
Title: Pneumococcal vaccines; use of rivaroxaban for DVT and PE.
Journal: JAAPA : official journal of the American Academy of Physician Assistants20120701
Title: Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban.
Journal: Journal of thrombosis and haemostasis : JTH20120701
Title: Oral rivaroxaban for pulmonary embolism.
Journal: The New England journal of medicine20120628
Title: Oral rivaroxaban for pulmonary embolism.
Journal: The New England journal of medicine20120628
Title: Oral rivaroxaban for pulmonary embolism.
Journal: The New England journal of medicine20120628
Title: Apixaban: a review of its use in the prevention of venous thromboembolism after knee or hip replacement surgery.
Journal: Drugs20120618
Title: New oral anticoagulants for venous thromboembolism: focus on factor Xa and thrombin inhibitors.
Journal: Current drug discovery technologies20120601
Title: Discovery of anticoagulant drugs: a historical perspective.
Journal: Current drug discovery technologies20120601
Title: Spontaneous spinal epidural haematoma during Factor Xa inhibitor treatment (Rivaroxaban).
Journal: European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society20120601
Title: The use of rivaroxaban for short- and long-term treatment of venous thromboembolism.
Journal: Thrombosis and haemostasis20120601
Title: Novel oral anticoagulants after acute coronary syndromes.
Journal: Cardiovascular drugs and therapy20120601
Title: Role of new anticoagulants for the prevention of venous thromboembolism after major orthopaedic surgery and in hospitalised acutely ill medical patients.
Journal: Thrombosis and haemostasis20120601
Title: New anticoagulant drugs for treatment of venous thromboembolism and stroke prevention in atrial fibrillation.
Journal: Journal of internal medicine20120601
Title: Novel antithrombotic agents for atrial fibrillation.
Journal: Pharmacology & therapeutics20120601
Title: Long-term benefits of preventing venous thromboembolic events.
Journal: Current medical research and opinion20120601
Title: [New anticoagulant drugs for atrial fibrillation. Feasibility and necessity of monitoring].
Journal: Herz20120601
Title: [Pharmacology of the new oral anticoagulants].
Journal: Herz20120601
Title: [Role of the new oral anticoagulants in comparison to vitamin K antagonists in practice].
Journal: Herz20120601
Title: [Anticoagulation. Modern concepts].
Journal: Herz20120601
Title: Current and future alternatives to warfarin for the prevention of stroke in atrial fibrillation.
Journal: Critical pathways in cardiology20120601
Title: A guidance pathway for the selection of novel anticoagulants in the treatment of atrial fibrillation.
Journal: Critical pathways in cardiology20120601
Title: The emergence of factor Xa inhibitors for the treatment of cardiovascular diseases: a patent review.
Journal: Expert opinion on therapeutic patents20120601
Title: Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Journal: Advances in therapy20120601
Title: Rivaroxaban, an oral, direct factor Xa inhibitor: a new option for thromboprophylaxis.
Journal: Orthopedics20120601
Title: Efficacy of extramedullary femoral component alignment guide system for blood saving after total knee arthroplasty.
Journal: Knee surgery & related research20120601
Title: Development and clinical applications of novel oral anticoagulants. Part I. Clinically approved drugs.
Journal: Discovery medicine20120601
Title: Rivaroxaban for thromboprophylaxis after hip or knee replacement surgery.
Journal: The Nurse practitioner20120511
Title: Anticoagulant therapy for patients with ischaemic stroke.
Journal: Nature reviews. Neurology20120508
Title: Venous thromboembolism: EINSTEIN transforms anticoagulant therapy in acute PE.
Journal: Nature reviews. Cardiology20120508
Title: Dabigatran etexilate: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
Journal: Drugs20120507
Title: Switching from enoxaparin to dabigatran etexilate: pharmacokinetics, pharmacodynamics, and safety profile.
Journal: European journal of clinical pharmacology20120501
Title: Tissue factor-driven thrombin generation and inflammation in atherosclerosis.
Journal: Thrombosis research20120501
Title: Reversal of antithrombotic agents.
Journal: American journal of hematology20120501
Title: Advances in laboratory testing for thrombophilia.
Journal: American journal of hematology20120501
Title: Guidance on the emergent reversal of oral thrombin and factor Xa inhibitors.
Journal: American journal of hematology20120501
Title: Implementing the new oral anticoagulants into the hospital formulary.
Journal: American journal of hematology20120501
Title: Prevention of venous thromboembolism in total knee and hip replacement.
Journal: Circulation20120501
Title: Novel oral anticoagulants--key messages for the angiologist.
Journal: VASA. Zeitschrift fur Gefasskrankheiten20120501
Title: New oral anticoagulants: will they replace warfarin?
Journal: Oral surgery, oral medicine, oral pathology and oral radiology20120501
Title: Oral anticoagulants for atrial fibrillation: Which one to choose?
Journal: Advance for NPs & PAs20120501
Title: Newer oral anticoagulant agents: a new era in medicine.
Journal: Current cardiology reviews20120501
Title: Letter by Bernstein et al regarding article, 'reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Journal: Circulation20120424
Title: Letter by Marlu et al regarding article, 'reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects'.
Journal: Circulation20120424
Title: [Therapy of pulmonary embolism. Rivaroxaban is superior to standard therapy].
Journal: MMW Fortschritte der Medizin20120419
Title: New oral anticoagulants in atrial fibrillation and acute coronary syndromes: ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease position paper.
Journal: Journal of the American College of Cardiology20120417
Title: Rivaroxaban to prevent pulmonary embolism after hip or knee replacement.
Journal: Circulation20120410
Title: Oral rivaroxaban for the treatment of symptomatic pulmonary embolism.
Journal: The New England journal of medicine20120405
Title: Rivaroxaban: Quantification by anti-FXa assay and influence on coagulation tests: a study in 9 Swiss laboratories.
Journal: Thrombosis research20120401
Title: Novel anticoagulants for atrial fibrillation: a critical appraisal.
Journal: Angiology20120401
Title: Should deep venous thrombosis prophylaxis be used in fast-track hip and knee replacement?
Journal: Acta orthopaedica20120401
Title: Rivaroxaban and recurrent stroke prevention in AF.
Journal: The Lancet. Neurology20120401
Title: Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.
Journal: The Lancet. Neurology20120401
Title: New oral anticoagulants for atrial fibrillation: a review of clinical trials.
Journal: Clinical therapeutics20120401
Title: Rivaroxaban: a new oral anticoagulant.
Journal: Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses20120401
Title: Preventing venous thromboembolic events after total hip arthroplasty: new developments in clinical practice.
Journal: Hospital practice (1995)20120401
Title: Thromboprophylaxis in surgical and medical patients.
Journal: Seminars in respiratory and critical care medicine20120401
Title: Beyond warfarin: the new generation of oral anticoagulants and their implications for the management of dental patients.
Journal: Oral surgery, oral medicine, oral pathology and oral radiology20120401
Title: How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch.
Journal: Blood20120329
Title: [Prophylaxis of stroke and embolisms in atrial fibrillation--what is new in the guidelines?].
Journal: MMW Fortschritte der Medizin20120322
Title: Rivaroxaban vs. warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.
Journal: American family physician20120315
Title: Net clinical benefit of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus no treatment in a 'real world' atrial fibrillation population: a modelling analysis based on a nationwide cohort study.
Journal: Thrombosis and haemostasis20120301
Title: Old and new oral anticoagulants for venous thromboembolism and atrial fibrillation: a review of the literature.
Journal: Thrombosis research20120301
Title: Utility of a physiologically-based pharmacokinetic (PBPK) modeling approach to quantitatively predict a complex drug-drug-disease interaction scenario for rivaroxaban during the drug review process: implications for clinical practice.
Journal: Biopharmaceutics & drug disposition20120301
Title: What's the 'go to' anticoagulant for stroke prevention in atrial fibrillation?
Journal: Thrombosis and haemostasis20120301
Title: New directions in anticoagulation.
Journal: The American journal of medicine20120301
Title: A new generation of oral direct anticoagulants.
Journal: Arteriosclerosis, thrombosis, and vascular biology20120301
Title: Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents.
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology20120301
Title: Highlights of the American Heart Association Scientific Sessions 2011: a focus on ATLAS-TIMI 51, TRACER and PALLAS.
Journal: Expert review of cardiovascular therapy20120301
Title: Coagulopathies and thrombosis: usual and unusual causes and associations, part VI.
Journal: Seminars in thrombosis and hemostasis20120301
Title: Determination of rivaroxaban in human plasma samples.
Journal: Seminars in thrombosis and hemostasis20120301
Title: The efficacy and safety of postoperative autologous transfusion of filtered shed blood and anticoagulant prophylaxis in total knee arthroplasty patients.
Journal: Knee surgery & related research20120301
Title: Oral direct factor Xa inhibitors for stroke prevention in atrial fibrillation.
Journal: Nature reviews. Cardiology20120227
Title: Oral factor Xa inhibitors for the long-term management of ACS.
Journal: Nature reviews. Cardiology20120221
Title: Heparin-induced thrombocytopenia: in vitro studies on the interaction of dabigatran, rivaroxaban, and low-sulfated heparin, with platelet factor 4 and anti-PF4/heparin antibodies.
Journal: Blood20120202
Title: Anticoagulant management in the cardiovascular setting.
Journal: Fundamental & clinical pharmacology20120201
Title: Pharmacodynamic and pharmacokinetic basics of rivaroxaban.
Journal: Fundamental & clinical pharmacology20120201
Title: Rivaroxaban for the prevention and treatment of venous thromboembolism.
Journal: Fundamental & clinical pharmacology20120201
Title: New anticoagulants for the prevention of stroke in atrial fibrillation.
Journal: Fundamental & clinical pharmacology20120201
Title: Lack of an antagonist to reverse the action of dabigatran.
Journal: QJM : monthly journal of the Association of Physicians20120201
Title: Management of coagulation: an Australian perspective.
Journal: Current opinion in anaesthesiology20120201
Title: Evaluation of the anti-factor Xa chromogenic assay for the measurement of rivaroxaban plasma concentrations using calibrators and controls.
Journal: Thrombosis and haemostasis20120201
Title: Cost effectiveness of rivaroxaban versus enoxaparin for prevention of post-surgical venous thromboembolism from a U.S. payer's perspective.
Journal: PharmacoEconomics20120201
Title: Cost-effectiveness of pharmacologic and invasive therapies for stroke prophylaxis in atrial fibrillation.
Journal: Journal of cardiovascular medicine (Hagerstown, Md.)20120201
Title: The year in Cardiothoracic and Vascular Anesthesia: selected highlights from 2011.
Journal: Journal of cardiothoracic and vascular anesthesia20120201
Title: The king is dead (warfarin): direct thrombin and factor Xa inhibitors: the next Diadochian War?
Journal: International journal of stroke : official journal of the International Stroke Society20120201
Title: Determination of the anticoagulant effects of new oral anticoagulants: an unmet need.
Journal: Expert review of hematology20120201
Title: Rivaroxaban: a review of its use for the prophylaxis of venous thromboembolism after total hip or knee replacement surgery.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions20120201
Title: Direct thrombin inhibitors and factor Xa inhibitors in patients with cerebrovascular disease.
Journal: Expert review of neurotherapeutics20120201
Title: Active online assessment of patients using new oral anticoagulants: bleeding risk, compliance, and coagulation analysis.
Journal: Seminars in thrombosis and hemostasis20120201
Title: Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Journal: Chest20120201
Title: Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Journal: Chest20120201
Title: Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Journal: Chest20120201
Title: [Expanded arsenal in atrial fibrillation: bye-bye marcumar?].
Journal: MMW Fortschritte der Medizin20120119
Title: Rivaroxaban reduced stroke and systemic embolism compared with warfarin in nonvalvular AF.
Journal: Annals of internal medicine20120117
Title: Rivaroxaban in patients with a recent acute coronary syndrome.
Journal: The New England journal of medicine20120105
Title: A new era in secondary prevention after acute coronary syndrome.
Journal: The New England journal of medicine20120105
Title: New anticoagulants - promising and failed developments.
Journal: British journal of pharmacology20120101
Title: Novel oral anticoagulants: new challenges for anesthesiologists in bleeding patients.
Journal: Anesthesiology20120101
Title: Optimisation of the assays for the measurement of clotting factor activity in the presence of rivaroxaban.
Journal: Thrombosis research20120101
Title: Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model.
Journal: Anesthesiology20120101
Title: Concerns about studies investigating new anticoagulant drugs for stroke prevention in atrial fibrillation.
Journal: Journal of neurology20120101
Title: [Anticoagulation in atrial fibrillation: a new era has begun].
Journal: Hamostaseologie20120101
Title: [Anticoagulation for atrial fibrillation : the future has begun].
Journal: Der Internist20120101
Title: Meta-analysis of cause of death following total joint replacement using different thromboprophylaxis regimens.
Journal: The Journal of bone and joint surgery. British volume20120101
Title: [Apixaban: pharmacology and action profile].
Journal: Deutsche medizinische Wochenschrift (1946)20120101
Title: New frontiers for stroke prevention in atrial fibrillation.
Journal: Cerebrovascular diseases (Basel, Switzerland)20120101
Title: [Summary of the article: Patel MR, Mahaffey KW, Garg J et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med, 2011; 365: 1557-1559].
Journal: Kardiologia polska20120101
Title: ARISTOTLE RE-LYs on the ROCKET. What's new in stroke prevention in patients with atrial fibrillation?
Journal: Cardiology journal20120101
Title: New antiplatelet and anticoagulant drugs.
Journal: General dentistry20120101
Title: Anticoagulation prophylaxis in orthopedic surgery: an efficiency frontier approach.
Journal: Postgraduate medicine20120101
Title: New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders.
Journal: Vascular health and risk management20120101
Title: I recently heard that there are alternative medications to the blood thinner warfarin. What are they, and how are they different?
Journal: DukeMedicine healthnews20120101
Title: A new era for anticoagulation in atrial fibrillation. Which anticoagulant should we choose for long‑term prevention of thromboembolic complications in patients with atrial fibrillation?
Journal: Polskie Archiwum Medycyny Wewnetrznej20120101
Title: Newer anticoagulants in cardiovascular disease: a systematic review of the literature.
Journal: Cardiology in review20120101
Title: Upcoming oral factor Xa inhibitors for venous thromboembolism prophylaxis in patients undergoing major orthopedic surgery: rivaroxaban (Xarelto) and apixaban (Eliquis) review.
Journal: Connecticut medicine20120101
Title: Improving prevention and treatment of venous thromboembolism: clinical trial results.
Journal: Journal of medical economics20120101
Title: Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls: results of a multicenter field trial.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis20120101
Title: The WATCHMAN left atrial appendage closure device for atrial fibrillation.
Journal: Journal of visualized experiments : JoVE20120101
Title: Stroke Prevention in Atrial Fibrillation: Where are We Now?
Journal: Clinical Medicine Insights. Cardiology20120101
Title: Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
Journal: The Canadian journal of cardiology20120101
Title: [Update on current care guidelines: atrial fibrillation].
Journal: Duodecim; laaketieteellinen aikakauskirja20120101
Title: Medical cost reductions associated with the usage of novel oral anticoagulants vs warfarin among atrial fibrillation patients, based on the RE-LY, ROCKET-AF, and ARISTOTLE trials.
Journal: Journal of medical economics20120101
Title: The Anticoagulation of Calf Thrombosis (ACT) project: study protocol for a randomized controlled trial.
Journal: Trials20120101
Title: Cost-effectiveness of rivaroxaban in the prevention of venous thromboembolism: A Canadian analysis using the Ontario Ministry of Health Perspective.
Journal: Journal of medical economics20120101
Title: Current status of new anticoagulants in the management of venous thromboembolism.
Journal: Advances in hematology20120101
Title: Costs and clinical consequences of suboptimal atrial fibrillation management.
Journal: ClinicoEconomics and outcomes research : CEOR20120101
Title: The Interface between Inflammation and Coagulation in Cardiovascular Disease.
Journal: International journal of inflammation20120101
Title: Efficacy and safety of venous thromboembolism prophylaxis with apixaban in major orthopedic surgery.
Journal: Therapeutics and clinical risk management20120101
Title: Oral anticoagulants. New oral anticoagulants for atrial fibrillation: the factor Xa inhibitors rivaroxaban and apixaban.
Journal: Reviews in cardiovascular medicine20120101
Title: The economic impact of enoxaparin versus unfractionated heparin for prevention of venous thromboembolism in acute ischemic stroke patients.
Journal: ClinicoEconomics and outcomes research : CEOR20120101
Title: Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants.
Journal: Journal of blood medicine20120101
Title: Anticoagulant and antiplatelet therapy in patients with atrial fibrillation and coronary artery disease.
Journal: Thrombosis20120101
Title: Acute-onset severe gastrointestinal tract hemorrhage in a postoperative patient taking rivaroxaban after total hip arthroplasty: a case report.
Journal: Journal of medical case reports20120101
Title: [New antithrombotic drugs].
Journal: Duodecim; laaketieteellinen aikakauskirja20120101
Title: Advances in the diagnosis and treatment of acute pulmonary embolism.
Journal: F1000 medicine reports20120101
Title: Reviewing the medical literature: five notable articles in general internal medicine from 2010 and 2011.
Journal: Open medicine : a peer-reviewed, independent, open-access journal20120101
Title: Therapeutic dosing of acenocoumarol: proposal of a population specific pharmacogenetic dosing algorithm and its validation in north Indians.
Journal: PloS one20120101
Title: Dabigatran for stroke prevention in nonvalvular atrial fibrillation: answers to challenging 'real-world' questions.
Journal: Thrombosis20120101
Title: Newer anticoagulants for the prevention of venous thromboembolism.
Journal: The National medical journal of India20120101
Title: Emerging anticoagulants.
Journal: Current medicinal chemistry20120101
Title: Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons.
Journal: BMJ (Clinical research ed.)20120101
Title: Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery.
Journal: Vascular health and risk management20120101
Title: Health technology assessment and its role in the future development of the Indian healthcare sector.
Journal: Perspectives in clinical research20120101
Title: [Rivaroxaban in the prevention and treatment of thromboembolic disorders].
Journal: Hamostaseologie20120101
Title: [New anticoagulants: dabigatran, rivaroxaban and apixaban].
Journal: Gaceta medica de Mexico20120101
Title: An evidence-based review of apixaban and its potential in the prevention of stroke in patients with atrial fibrillation.
Journal: Core evidence20120101
Title: Emerging anticoagulant therapies for atrial fibrillation: new options, new challenges.
Journal: Current medicinal chemistry20120101
Title: Perioperative stroke risk in nonvascular surgery.
Journal: Cerebrovascular diseases (Basel, Switzerland)20120101
Title: Vitamin K antagonists. Ready to be replaced?
Journal: Hamostaseologie20120101
Title: Understanding the new emerging oral anticoagulants for venous thromboembolism prophylaxis.
Journal: Orthopedic nursing20120101
Title: Rivaroxaban in atrial fibrillation.
Journal: Vascular health and risk management20120101
Title: Prevention of stroke and systemic embolization in atrial fibrillation: a Canadian perspective.
Journal: Polskie Archiwum Medycyny Wewnetrznej20120101
Title: Stroke prevention in atrial fibrillation: understanding the new oral anticoagulants dabigatran, rivaroxaban, and apixaban.
Journal: Thrombosis20120101
Title: [New oral anticoagulants for atrial fibrillation: a neurologist's view].
Journal: Nederlands tijdschrift voor geneeskunde20120101
Title: Management of venous thromboembolism in patients with advanced gastrointestinal cancers: what is the role of novel oral anticoagulants?
Journal: Thrombosis20120101
Title: Thromboembolic prophylaxis in total joint arthroplasty.
Journal: Thrombosis20120101
Title: Coronary and mortality risk of novel oral antithrombotic agents: a meta-analysis of large randomised trials.
Journal: BMJ open20120101
Title: [Therapeutic approach to the bleeding in association with 'old' and 'new' anticoagulants].
Journal: Vnitrni lekarstvi20120101
Title: [Risk of bleeding and haemorrhagic complication with rivaroxaban--periprocedural management of haemostasis].
Journal: Hamostaseologie20120101
Title: Left atrial appendage exclusion for stroke prevention in atrial fibrillation.
Journal: Cardiology research and practice20120101
Title: Rationalizing tight ligand binding through cooperative interaction networks.
Journal: Journal of chemical information and modeling20111227
Title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Journal: The New England journal of medicine20111215
Title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Journal: The New England journal of medicine20111215
Title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Journal: The New England journal of medicine20111215
Title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Journal: The New England journal of medicine20111215
Title: Rivaroxaban (Xarelto) for acute coronary syndrome.
Journal: The Medical letter on drugs and therapeutics20111212
Title: Discovery of N-[2-hydroxy-6-(4-methoxybenzamido)phenyl]-4- (4-methyl-1,4-diazepan-1-yl)benzamide (darexaban, YM150) as a potent and orally available factor Xa inhibitor.
Journal: Journal of medicinal chemistry20111208
Title: Antiplatelet agents and anticoagulants for hypertension.
Journal: The Cochrane database of systematic reviews20111207
Title: Drugs in traffic: the road to approval.
Journal: Nature medicine20111206
Title: Effect of multiple doses of omeprazole on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban.
Journal: Journal of cardiovascular pharmacology20111201
Title: New anticoagulants: moving on from scientific results to clinical implementation.
Journal: Annals of medicine20111201
Title: Determination of an international sensitivity index of thromboplastin reagents using a WHO thromboplastin as calibrator for plasma spiked with rivaroxaban.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis20111201
Title: Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosis.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis20111201
Title: Intraarticular vs. extraarticular ropivacaine infusion following high-dose local infiltration analgesia after total knee arthroplasty: a randomized double-blind study.
Journal: Acta orthopaedica20111201
Title: [Stabilization of inter- and subtrochanteric femoral fractures with the PFNΑ®].
Journal: Operative Orthopadie und Traumatologie20111201
Title: Laboratory testing of anticoagulants: the present and the future.
Journal: Pathology20111201
Title: [Thrombosis prophylaxis in surgery. What is the evidence?].
Journal: Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen20111201
Title: Antithrombotic therapy in nonvalvular atrial fibrillation: a narrative review.
Journal: Revista portuguesa de cardiologia : orgao oficial da Sociedade Portuguesa de Cardiologia = Portuguese journal of cardiology : an official journal of the Portuguese Society of Cardiology20111201
Title: Role of pharmacogenomics in the management of traditional and novel oral anticoagulants.
Journal: Pharmacotherapy20111201
Title: [Pharmacologic heterogeneity of new anticoagulants].
Journal: Journal des maladies vasculaires20111201
Title: [New treatments for venous thromboembolic disease].
Journal: Journal des maladies vasculaires20111201
Title: [Secondary prevention of myocardial infarct. A new anticoagulant improves survival prospects].
Journal: MMW Fortschritte der Medizin20111201
Title: [Rivaroxaban is not inferior compared with warfarin as an anticoagulant in patients with non-valvular atrial fibrillation].
Journal: Praxis20111130
Title: Acute coronary syndromes: Rivaroxaban reduces serious CV events without increasing fatal bleeding in patients with a recent ACS.
Journal: Nature reviews. Cardiology20111129
Title: FDA advisory decision highlights some problems inherent in pragmatic trials.
Journal: JAMA20111102
Title: Bleeding, vertebral fractures and vascular calcifications in patients treated with warfarin: hope for lower risks with alternative therapies.
Journal: Current vascular pharmacology20111101
Title: Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study.
Journal: Journal of thrombosis and thrombolysis20111101
Title: Rationale and current perspective for early rhythm control therapy in atrial fibrillation.
Journal: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology20111101
Title: Interference of rivaroxaban in one-stage and chromogenic factor VIII:C assays.
Journal: Thrombosis and haemostasis20111101
Title: [New anticoagulants. Characteristics, monitoring and management of bleeding].
Journal: Medizinische Klinik, Intensivmedizin und Notfallmedizin20111101
Title: A study of thromboprophylactic practices of Scottish orthopaedic surgeons in patients undergoing total hip replacements. Should practice change with new guidelines?
Journal: Scottish medical journal20111101
Title: [Effect of rivaroxaban on risk of bleeding after total knee arthroplasty].
Journal: Zhongguo xiu fu chong jian wai ke za zhi = Zhongguo xiufu chongjian waike zazhi = Chinese journal of reparative and reconstructive surgery20111101
Title: [Current status and future of anti-Xa inhibitors].
Journal: Rinsho shinkeigaku = Clinical neurology20111101
Title: [New anticoagulants].
Journal: La Revue du praticien20111101
Title: Evaluating rivaroxaban for nonvalvular atrial fibrillation--regulatory considerations.
Journal: The New England journal of medicine20111027
Title: Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
Journal: Circulation20111004
Title: Reversal of new oral anticoagulants.
Journal: Circulation20111004
Title: Oral rivaroxaban for acute DVT, or long term for VTE, is as effective as enoxaparin followed by a vitamin K antagonist for preventing recurrence, with no increase in bleeding complications.
Journal: Evidence-based medicine20111001
Title: Inhibitors of propagation of coagulation: factors V and X.
Journal: British journal of clinical pharmacology20111001
Title: A role for coagulation factor Xa in experimental pulmonary arterial hypertension.
Journal: Cardiovascular research20111001
Title: New anticoagulants: how to deal with treatment failure and bleeding complications.
Journal: British journal of clinical pharmacology20111001
Title: Impact of venous thromboembolism on clinical management and therapy after hip and knee arthroplasty.
Journal: Canadian journal of surgery. Journal canadien de chirurgie20111001
Title: Effect of rivaroxaban, in contrast to heparin, is similar in neonatal and adult plasma.
Journal: Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis20111001
Title: Determination of rivaroxaban by different factor Xa specific chromogenic substrate assays: reduction of interassay variability.
Journal: Journal of thrombosis and thrombolysis20111001
Title: Anticoagulating obese patients in the modern era.
Journal: British journal of haematology20111001
Title: Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.
Journal: European heart journal20111001
Title: RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome.
Journal: European heart journal20111001
Title: Rivaroxaban: population pharmacokinetic analyses in patients treated for acute deep-vein thrombosis and exposure simulations in patients with atrial fibrillation treated for stroke prevention.
Journal: Clinical pharmacokinetics20111001
Title: New and emerging anticoagulant therapy for atrial fibrillation and acute coronary syndrome.
Journal: Pharmacotherapy20111001
Title: Novel oral anticoagulants for VTE prevention in orthopedic surgery: overview of phase 3 trials.
Journal: Orthopedics20111001
Title: Cost-effectiveness of rivaroxaban versus heparins for prevention of venous thromboembolism after total hip or knee surgery in Sweden.
Journal: Expert review of pharmacoeconomics & outcomes research20111001
Title: Dutch guideline on total hip prosthesis.
Journal: Acta orthopaedica20111001
Title: The new oral anticoagulants.
Journal: Clinical medicine (London, England)20111001
Title: Xarelto: a new drug for new joints. Hip and knee recipients can avoid postsurgical clots without undergoing painful injections.
Journal: The Johns Hopkins medical letter health after 5020111001
Title: [New antithrombotic drugs for the treatment of venous thromboembolism].
Journal: Revue des maladies respiratoires20111001
Title: [Atrial fibrillation: what the GP needs to know].
Journal: MMW Fortschritte der Medizin20110922
Title: [Modern risk assessment and stroke prevention in atrial fibrillation].
Journal: Praxis20110921
Title: A new era for anticoagulation in atrial fibrillation.
Journal: The New England journal of medicine20110915
Title: Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Journal: The New England journal of medicine20110908
Title: New options in anticoagulation for atrial fibrillation.
Journal: The New England journal of medicine20110908
Title: Safety and efficacy of rivaroxaban for thromboprophylaxis following lower limb surgery: an update.
Journal: Expert opinion on drug safety20110901
Title: Emerging options in the treatment of deep vein thrombosis and pulmonary embolism.
Journal: Blood reviews20110901
Title: Prevention of venous thromboembolism after major orthopedic surgery: indirect comparison of three new oral anticoagulants.
Journal: Journal of thrombosis and haemostasis : JTH20110901
Title: Direct inhibitors of thrombin and factor Xa attenuate clot-induced mitogenesis and inflammatory gene expression in human vascular smooth muscle cells.
Journal: Thrombosis and haemostasis20110901
Title: Update on anti-coagulation in atrial fibrillation.
Journal: QJM : monthly journal of the Association of Physicians20110901
Title: [Thromboembolic prophylaxis 2011: is warfarin on the wane?].
Journal: Giornale italiano di cardiologia (2006)20110901
Title: Rivaroxaban: direct factor Xa inhibition to treat acute deep vein thrombosis.
Journal: British journal of hospital medicine (London, England : 2005)20110901
Title: Direct thrombin inhibitors for the treatment of venous thromboembolism: analysis of the Dabigatran versus Warfarin clinical trial.
Journal: Seminars in vascular surgery20110901
Title: Rivaroxaban (Xarelto)--a new oral anticoagulant.
Journal: The Medical letter on drugs and therapeutics20110822
Title: New antithrombotic drugs and European approval processes.
Journal: Lancet (London, England)20110820
Title: Oral direct factor Xa inhibitor gets FDA's OK.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20110815
Title: Polysulfated xanthones: multipathway development of a new generation of dual anticoagulant/antiplatelet agents.
Journal: Journal of medicinal chemistry20110811
Title: [The new Anticoagulants - Relevant Facts for the GP].
Journal: Praxis20110810
Title: [Rivaroxaban as therapy of deep venous thrombosis equally as effective as current anticoagulation with heparin and vitamin K antagonist].
Journal: Praxis20110810
Title: ['Xa-tra-xa': opportunities and open questions about new anticoagulants].
Journal: Praxis20110810
Title: Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism.
Journal: European heart journal20110801
Title: Incidence of chronic kidney disease in patients with atrial fibrillation and its relevance for prescribing new oral antithrombotic drugs.
Journal: Journal of thrombosis and haemostasis : JTH20110801
Title: New anticoagulants for prevention of stroke in patients with atrial fibrillation.
Journal: Journal of cardiovascular electrophysiology20110801
Title: Detection of lupus anticoagulant in the presence of rivaroxaban using Taipan snake venom time.
Journal: Journal of thrombosis and haemostasis : JTH20110801
Title: Role of emerging antithrombotic therapy in the prevention of cardioembolic complications in patients with atrial fibrillation.
Journal: American journal of cardiovascular drugs : drugs, devices, and other interventions20110801
Title: New oral anticoagulants for venous thromboembolism (VTE) prophylaxis.
Journal: The Medical journal of Malaysia20110801
Title: Novel oral anticoagulants in development: Dabigatran, Rivaroxaban, and Apixaban.
Journal: American journal of therapeutics20110701
Title: In vitro and in vivo P-glycoprotein transport characteristics of rivaroxaban.
Journal: The Journal of pharmacology and experimental therapeutics20110701
Title: Clinical trials of direct thrombin and factor Xa inhibitors in atrial fibrillation.
Journal: Current opinion in cardiology20110701
Title: Rivaroxaban differentially influences ex vivo global coagulation assays based on the administration time.
Journal: Thrombosis and haemostasis20110701
Title: Response to 'Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban'.
Journal: Journal of clinical pharmacology20110701
Title: Practical aspects of the oral new anticoagulants.
Journal: American journal of hematology20110701
Title: Treatment of risk factors to prevent stroke.
Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics20110701
Title: Optimal duration of anticoagulation in patients with venous thromboembolism.
Journal: The Indian journal of medical research20110701
Title: Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-extension study).
Journal: Expert review of cardiovascular therapy20110701
Title: [New anticoagulants in the prevention and treatment of venous thromboembolism].
Journal: Orvosi hetilap20110619
Title: The mechanism of action of rivaroxaban--an oral, direct Factor Xa inhibitor--compared with other anticoagulants.
Journal: Thrombosis research20110601
Title: Atrial fibrillation and percutaneous coronary intervention: stroke, thrombosis, and bleeding.
Journal: Current treatment options in cardiovascular medicine20110601
Title: Treating arrhythmias: an expert opinion.
Journal: Expert opinion on pharmacotherapy20110601
Title: A systematic review of rivaroxaban versus enoxaparin in the prevention of venous thromboembolism after hip or knee replacement.
Journal: Thrombosis research20110601
Title: Rivaroxaban in the contemporary treatment of acute coronary syndromes.
Journal: Expert opinion on investigational drugs20110601
Title: Review of an article: oral rivaroxaban for symptomatic venous thromboembolism. The EINSTEIN Investigators et al. N Engl J Med 2010; 363(26):2499-2510.
Journal: Journal of vascular nursing : official publication of the Society for Peripheral Vascular Nursing20110601
Title: Prophylaxis of venous thromboembolism: low molecular weight heparin compared to the selective anticoagulants rivaroxaban, dabigatran and fondaparinux.
Journal: International angiology : a journal of the International Union of Angiology20110601
Title: Economic impact of venous thromboembolism after hip and knee arthroplasty: potential impact of rivaroxaban.
Journal: Expert review of pharmacoeconomics & outcomes research20110601
Title: 4-(3-Fluoro-4-nitro-phen-yl)morpholin-3-one.
Journal: Acta crystallographica. Section E, Structure reports online20110601
Title: [Is the era from the end of warfarin?].
Journal: Medizinische Monatsschrift fur Pharmazeuten20110601
Title: ACP journal club. Rivaroxaban was noninferior to enoxaparin for preventing short-term recurrent VTE and superior to placebo in continued treatment.
Journal: Annals of internal medicine20110517
Title: Update on pharmacologic approaches to prevent thromboembolism in atrial fibrillation: are thrombin and factor Xa inhibitors the ultimate answer?
Journal: Current vascular pharmacology20110501
Title: Is there evidence to support the use of direct Factor Xa inhibitors in coronary artery disease?
Journal: Reviews on recent clinical trials20110501
Title: Coagulation parameters in patients receiving dabigatran etexilate or rivaroxaban: two observational studies in patients undergoing total hip or total knee replacement.
Journal: Thrombosis research20110501
Title: Laboratory assessment of new anticoagulants.
Journal: Clinical chemistry and laboratory medicine20110501
Title: Preclinical discovery of apixaban, a direct and orally bioavailable factor Xa inhibitor.
Journal: Journal of thrombosis and thrombolysis20110501
Title: Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol.
Journal: Journal of thrombosis and thrombolysis20110501
Title: Risk-benefit ratio assessment for stroke prevention in intermediate risk atrial fibrillation patients: will TEE-based aspirin treatment fill the gap?
Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation20110501
Title: Rationale and design of the Anti-Xa therapy to lower cardiovascular events in addition to standard therapy in subjects with acute coronary syndrome-thrombolysis in myocardial infarction 51 (ATLAS-ACS 2 TIMI 51) trial: a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of rivaroxaban in subjects with acute coronary syndrome.
Journal: American heart journal20110501
Title: [New oral anticoagulant drugs: dabigatran, rivaroxaban and apixaban. Present and future].
Journal: Medecine sciences : M/S20110501
Title: Advances in cardiology: clinical trial update.
Journal: Future cardiology20110501
Title: [The new anticoagulants].
Journal: Harefuah20110501
Title: [Current and future therapies for prophylaxis of thromboembolism in atrial fibrillation].
Journal: MMW Fortschritte der Medizin20110414
Title: Coagulation-induced shedding of platelet glycoprotein VI mediated by factor Xa.
Journal: Blood20110407
Title: A phase I open-label study evaluating the cardiovascular safety of sorafenib in patients with advanced cancer.
Journal: Cancer chemotherapy and pharmacology20110401
Title: The potential role of new oral anticoagulants in the prevention and treatment of thromboembolism.
Journal: Pharmacology & therapeutics20110401
Title: Measuring the anticoagulant effect of direct factor Xa inhibitors. Is the anti-Xa assay preferable to the prothrombin time test?
Journal: Thrombosis and haemostasis20110401
Title: What do the RE-LY, AVERROES and ROCKET-AF trials tell us for stroke prevention in atrial fibrillation?
Journal: Thrombosis and haemostasis20110401
Title: New oral anticoagulants.
Journal: Journal of thrombosis and thrombolysis20110401
Title: Drug and dietary interactions of warfarin and novel oral anticoagulants: an update.
Journal: Journal of thrombosis and thrombolysis20110401
Title: Investigational factor Xa inhibitors for thrombosis and acute coronary syndromes.
Journal: Expert opinion on investigational drugs20110401
Title: Clinical trials update from the American Heart Association meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT.
Journal: European journal of heart failure20110401
Title: Preventing postsurgical venous thromboembolism: pharmacological approaches.
Journal: Seminars in thrombosis and hemostasis20110401
Title: Oral rivaroxaban for symptomatic venous thromboembolism.
Journal: The New England journal of medicine20110324
Title: Rivaroxaban for the prevention of venous thromboembolism after hip or knee arthroplasty. Pooled analysis of four studies.
Journal: Thrombosis and haemostasis20110301
Title: Italian intersociety consensus statement on antithrombotic prophylaxis in hip and knee replacement and in femoral neck fracture surgery.
Journal: Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology20110301
Title: Changing anticoagulant paradigms for atrial fibrillation: dabigatran, apixaban and rivaroxaban.
Journal: Expert opinion on pharmacotherapy20110301
Title: Old and new anticoagulant drugs: a minireview.
Journal: Annals of medicine20110301
Title: Use of low-molecular-weight heparins and new anticoagulants in elderly patients with renal impairment.
Journal: Drugs & aging20110301
Title: Evaluation of drug-induced serious hepatotoxicity (eDISH): application of this data organization approach to phase III clinical trials of rivaroxaban after total hip or knee replacement surgery.
Journal: Drug safety20110301
Title: The discovery and development of rivaroxaban.
Journal: Annals of the New York Academy of Sciences20110301
Title: Pharmacokinetics and pharmacodynamics of rivaroxaban and its effect on biomarkers of hypercoagulability in patients with chronic heart failure.
Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation20110201
Title: Rivaroxaban and false positive lupus anticoagulant testing.
Journal: Thrombosis and haemostasis20110201
Title: New anticoagulant agents in acute coronary syndromes.
Journal: Heart (British Cardiac Society)20110201
Title: Dabigatran and rivaroxaban for prevention of venous thromboembolism--systematic review and adjusted indirect comparison.
Journal: Journal of clinical pharmacy and therapeutics20110201
Title: Novel anticoagulants: a discussion of clinical use in the treatment and prevention of venous thromboembolism.
Journal: Phlebology20110201
Title: [New oral anticoagulants in atrial fibrillation].
Journal: Der Nervenarzt20110201
Title: Association of warfarin use with valvular and vascular calcification: a review.
Journal: Clinical cardiology20110201
Title: Old and new anticoagulants.
Journal: Hamostaseologie20110201
Title: New anticoagulants: pharmacology and clinical studies.
Journal: Wiener medizinische Wochenschrift (1946)20110201
Title: Direct thrombin and factor Xa inhibitors in children: a quest for new anticoagulants for children.
Journal: Wiener medizinische Wochenschrift (1946)20110201
Title: New oral anticoagulants and outpatient prophylaxis of venous thromboembolism.
Journal: The American journal of managed care20110201
Title: Cost-effectiveness of rivaroxaban after total hip or total knee arthroplasty.
Journal: The American journal of managed care20110201
Title: Characteristics of novel anticoagulants and potential economic implications.
Journal: The American journal of managed care20110201
Title: Venous thromboembolism after total hip arthroplasty and total knee arthroplasty: current and future perspectives. Epilogue.
Journal: The American journal of managed care20110201
Title: Venous thromboembolism after total hip arthroplasty and total knee arthroplasty: current and future perspectives.
Journal: The American journal of managed care20110201
Title: New oral anticoagulants for thromboprophylaxis in patients having hip or knee arthroplasty.
Journal: BMJ (Clinical research ed.)20110118
Title: New alternative to warfarin may help reduce stroke risk in patients with AF.
Journal: JAMA20110105
Title: The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study.
Journal: Journal of thrombosis and haemostasis : JTH20110101
Title: Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.
Journal: Journal of thrombosis and haemostasis : JTH20110101
Title: Combination of a two-step fluorescence assay and a two-step anti-Factor Xa assay for detection of heparin falsifications and protein in heparins.
Journal: Analytical and bioanalytical chemistry20110101
Title: Novel anticoagulants: new evidence for emerging drugs and their potential application in major lower limb surgery.
Journal: Current vascular pharmacology20110101
Title: The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor.
Journal: Nature reviews. Drug discovery20110101
Title: Factor Xa and thrombin as targets for new oral anticoagulants.
Journal: Thrombosis research20110101
Title: Return to theatre following total hip and knee replacement, before and after the introduction of rivaroxaban: a retrospective cohort study.
Journal: The Journal of bone and joint surgery. British volume20110101
Title: Novel oral factor Xa and thrombin inhibitors in the management of thromboembolism.
Journal: Annual review of medicine20110101
Title: New oral anticoagulants: should they replace heparins and warfarin?
Journal: Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese20110101
Title: An indirect comparison, via enoxaparin, of rivaroxaban with dabigatran in the prevention of venous thromboembolism after hip or knee replacement.
Journal: Journal of medical economics20110101
Title: Cardiac crossroads: deciding between mechanical or bioprosthetic heart valve replacement.
Journal: Patient preference and adherence20110101
Title: [Perioperative venous thromboembolism prophylaxis].
Journal: La Revue du praticien20110101
Title: Heparin-induced thrombocytopenia in the ICU: an overview.
Journal: Critical care (London, England)20110101
Title: The pathology and treatment of cardiac arrhythmias: focus on atrial fibrillation.
Journal: Vascular health and risk management20110101
Title: Evaluation of the efficacy and safety of rivaroxaban using a computer model for blood coagulation.
Journal: PloS one20110101
Title: New oral anticoagulants for venous thromboembolism prophylaxis in orthopaedic surgery.
Journal: Instructional course lectures20110101
Title: Left Atrial Appendage Closure in Atrial Fibrillation: A World without Anticoagulation?
Journal: Cardiology research and practice20110101
Title: Study protocol: the DESPATCH study: delivering stroke prevention for patients with atrial fibrillation - a cluster randomised controlled trial in primary healthcare.
Journal: Implementation science : IS20110101
Title: [Drug prevention of pulmonary embolism in orthopedic practice: traditional and novel approaches].
Journal: Kardiologiia20110101
Title: Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trial.
Journal: BMJ (Clinical research ed.)20110101
Title: Evaluation of plaque stability of advanced atherosclerotic lesions in apo E-deficient mice after treatment with the oral factor Xa inhibitor rivaroxaban.
Journal: Mediators of inflammation20110101
Title: Battle of oral anticoagulants in the field of atrial fibrillation scrutinized from a clinical practice (the real world) perspective.
Journal: Thrombosis journal20110101
Title: Therapeutic potential of rivaroxaban in the prevention of venous thromboembolism following hip and knee replacement surgery: a review of clinical trial data.
Journal: Vascular health and risk management20110101
Title: Antithrombotic medication for cardioembolic stroke prevention.
Journal: Stroke research and treatment20110101
Title: Comparison of pharmacist managed anticoagulation with usual medical care in a family medicine clinic.
Journal: BMC family practice20110101
Title: Strategies for diagnosis and prevention of venous thromboembolism during pregnancy.
Journal: Journal of pregnancy20110101
Title: FDA approves rivaroxaban for prevention of deep-vein thrombosis in surgery.
Journal: Cardiovascular journal of Africa20110101
Title: Evaluation of marine brown algae and sponges from Brazil as anticoagulant and antiplatelet products.
Journal: Marine drugs20110101
Title: Anesthesia for joint replacement surgery: Issues with coexisting diseases.
Journal: Journal of anaesthesiology, clinical pharmacology20110101
Title: Tissue factor, blood coagulation, and beyond: an overview.
Journal: International journal of inflammation20110101
Title: Prophylaxis for deep vein thrombosis and pulmonary embolism in the surgical patient.
Journal: Advances in surgery20110101
Title: [The new oral anticoagulants in surgery].
Journal: Revista medica del Instituto Mexicano del Seguro Social20110101
Title: European Society of Cardiology congress 2011.
Journal: Cardiovascular journal of Africa20110101
Title: Role of factor xa inhibitors in cancer-associated thrombosis: any new data?
Journal: Advances in hematology20110101
Title: Cost and outcomes associated with rivaroxaban vs enoxaparin for the prevention of postsurgical venous thromboembolism from a US payer's perspective.
Journal: Journal of medical economics20110101
Title: Emerging therapies for acute coronary syndromes.
Journal: Frontiers in pharmacology20110101
Title: The effect of a new direct Factor Xa inhibitor on human osteoblasts: an in-vitro study comparing the effect of rivaroxaban with enoxaparin.
Journal: BMC musculoskeletal disorders20110101
Title: Dabigatran etexilate versus warfarin in management of non-valvular atrial fibrillation in UK context: quantitative benefit-harm and economic analyses.
Journal: BMJ (Clinical research ed.)20110101
Title: Rivaroxaban, ticagrelor, and fidaxomicin.
Journal: Journal of the American Pharmacists Association : JAPhA20110101
Title: Urinary Prothrombin Fragment 1+2 in relation to Development of Non-Symptomatic and Symptomatic Venous Thromboembolic Events following Total Knee Replacement.
Journal: Thrombosis20110101
Title: Venous thromboembolism: classification, risk factors, diagnosis, and management.
Journal: ISRN hematology20110101
Title: Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants.
Journal: Thrombosis journal20110101
Title: Anticoagulants and the propagation phase of thrombin generation.
Journal: PloS one20110101
Title: Gene-drug interaction in stroke.
Journal: Stroke research and treatment20110101
Title: Raft of rivaroxaban good news from the USA, implications for South African clinical practice.
Journal: Cardiovascular journal of Africa20110101
Title: Oral fondaparinux: use of lipid nanocapsules as nanocarriers and in vivo pharmacokinetic study.
Journal: International journal of nanomedicine20110101
Title: Cardiac arrest caused by multiple recurrent pulmonary embolism.
Journal: Case reports in medicine20110101
Title: Pharmacological basis and clinical evidence of dabigatran therapy.
Journal: Journal of hematology & oncology20110101
Title: The case for an elderly targeted stroke management.
Journal: Frontiers in neurology20110101
Title: Oral thromboprophylaxis following total hip or knee replacement: review and multicentre experience with dabigatran etexilate.
Journal: The open orthopaedics journal20110101
Title: Deep vein thrombosis: a clinical review.
Journal: Journal of blood medicine20110101
Title: Oral rivaroxaban for symptomatic venous thromboembolism.
Journal: The New England journal of medicine20101223
Title: Therapeutic potential of oral factor Xa inhibitors.
Journal: The New England journal of medicine20101223
Title: Engineered thrombin aims to take on heparin.
Journal: Chemistry & biology20101222
Title: Novel anticoagulants for stroke prevention in atrial fibrillation: current clinical evidence and future developments.
Journal: Journal of the American College of Cardiology20101214
Title: [Rivaroxaban at least as effective as marcumar in stroke prevention].
Journal: MMW Fortschritte der Medizin20101202
Title: [New oral anticoagulants: better than vitamin K antagonists?].
Journal: Der Internist20101201
Title: Assays for measuring rivaroxaban: their suitability and limitations.
Journal: Therapeutic drug monitoring20101201
Title: The new oral anticoagulants, do they change the benefit vs. risk for thromboprophylaxis in association to ambulatory surgery?
Journal: Current opinion in anaesthesiology20101201
Title: The impact of elective knee/hip replacement surgery and thromboprophylaxis with rivaroxaban or dalteparin on thrombin generation.
Journal: British journal of haematology20101201
Title: Clinical laboratory measurement of direct factor Xa inhibitors: anti-Xa assay is preferable to prothrombin time assay.
Journal: Thrombosis and haemostasis20101201
Title: New synthetic antithrombotic agents for venous thromboembolism: pentasaccharides, direct thrombin inhibitors, direct Xa inhibitors.
Journal: Clinics in chest medicine20101201
Title: Recurrent venous thrombosis despite 'optimal anticoagulation therapy' for antiphospholipid syndrome--could new oral anticoagulants solve the problem?
Journal: Acta clinica Croatica20101201
Title: Clinical pharmacology of direct and indirect factor Xa inhibitors.
Journal: Drugs20101112
Title: Is there adequate provision of venous thromboembolism prophylaxis following hip arthroplasty? An audit and international survey.
Journal: Annals of the Royal College of Surgeons of England20101101
Title: An optimised, rapid chromogenic assay, specific for measuring direct factor Xa inhibitors (rivaroxaban) in plasma.
Journal: Thrombosis and haemostasis20101101
Title: Rivaroxaban versus enoxaparin for thromboprophylaxis after total hip or knee arthroplasty: a meta-analysis of randomized controlled trials.
Journal: European journal of clinical pharmacology20101101
Title: Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials.
Journal: Circulation. Cardiovascular quality and outcomes20101101
Title: Blood transfusion and the anaesthetist: management of massive haemorrhage.
Journal: Anaesthesia20101101
Title: [Prophylaxis of thrombembolic diseases with rivaroxaban].
Journal: Deutsche medizinische Wochenschrift (1946)20101101
Title: Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor.
Journal: British journal of clinical pharmacology20101101
Title: Korean guidelines for the prevention of venous thromboembolism.
Journal: Journal of Korean medical science20101101
Title: [Novel anticoagulants for stroke prevention in atrial fibrillation].
Journal: Deutsche medizinische Wochenschrift (1946)20101101
Title: [New oral anticoagulants from the perspective of trauma surgery].
Journal: Der Unfallchirurg20101101
Title: [Thromboembolism prophylaxis in trauma surgery: S3 guidelines and significance of the amendment for trauma surgeons].
Journal: Der Unfallchirurg20101101
Title: [Recommendations for the administration of conventional and new antithrombotic agents from the perspective of anesthesiology].
Journal: Der Unfallchirurg20101101
Title: [Two new anticoagulants available in 2010--Dabigatran Etexilate and Rivaroxaban: expected progresses--raised problems].
Journal: Annales pharmaceutiques francaises20101101
Title: [New study findings in cardiology. The best is the enemy of the good].
Journal: Medizinische Monatsschrift fur Pharmazeuten20101101
Title: New options for stroke prevention in atrial fibrillation.
Journal: The American journal of managed care20101101
Title: Rivaroxaban: a novel anticoagulant.
Journal: Indian journal of medical sciences20101101
Title: New antithrombotics for atrial fibrillation.
Journal: Cardiovascular therapeutics20101001
Title: Emerging antithrombotic agents: what does the intensivist need to know?
Journal: Current opinion in critical care20101001
Title: Cost-effectiveness of rivaroxaban versus enoxaparin for the prevention of postsurgical venous thromboembolism in Canada.
Journal: Thrombosis and haemostasis20101001
Title: Low risk of thromboembolic complications after fast-track hip and knee arthroplasty.
Journal: Acta orthopaedica20101001
Title: Rivaroxaban for thromboembolism prophylaxis after orthopaedic surgery.
Journal: Anaesthesia20101001
Title: Factor Xa inhibitors: next-generation antithrombotic agents.
Journal: Journal of medicinal chemistry20100909
Title: Role of orally available antagonists of factor Xa in the treatment and prevention of thromboembolic disease: focus on rivaroxaban.
Journal: Journal of clinical pharmacology20100901
Title: [Oral prevention of thromboembolism with rivaroxaban and dabigatran: are the newly approved drugs innovations in orthopaedic and trauma surgery? ].
Journal: Zeitschrift fur Orthopadie und Unfallchirurgie20100901
Title: New antithrombotic agents--insights from clinical trials.
Journal: Nature reviews. Cardiology20100901
Title: Novel oral anticoagulants: implications in the perioperative setting.
Journal: Anesthesiology20100901
Title: [Rivaroxaban and factor Xa inhibitors in clinical practice].
Journal: Vnitrni lekarstvi20100901
Title: Antithrombotic and anticoagulant profiles of TAK-442, a novel factor Xa inhibitor, in a rabbit model of venous thrombosis.
Journal: Journal of cardiovascular pharmacology20100801
Title: Anticoagulation by factor Xa inhibitors.
Journal: Journal of thrombosis and haemostasis : JTH20100801
Title: Apixaban, a direct factor Xa inhibitor, inhibits tissue-factor induced human platelet aggregation in vitro: comparison with direct inhibitors of factor VIIa, XIa and thrombin.
Journal: Thrombosis and haemostasis20100801
Title: Treatment of thromboembolism in cancer patients.
Journal: Expert opinion on pharmacotherapy20100801
Title: Oral Xa inhibitors.
Journal: Hematology/oncology clinics of North America20100801
Title: [Do orally active factor Xa (FXa) inhibitors have potential as innovative new anticoagulants? Future perspective from preclinical data].
Journal: Nihon yakurigaku zasshi. Folia pharmacologica Japonica20100801
Title: Oral factor Xa inhibitors for the prevention of stroke in atrial fibrillation.
Journal: Current opinion in cardiology20100701
Title: New oral anticoagulant drugs in cardiovascular disease.
Journal: Thrombosis and haemostasis20100701
Title: Clot prevention--common questions about medications.
Journal: Australian family physician20100701
Title: [A new deal with new anticoagulants?].
Journal: Journal des maladies vasculaires20100601
Title: Old versus new anticoagulants: focus on pharmacology.
Journal: Recent patents on cardiovascular drug discovery20100601
Title: Anesthetic concerns for patients with coagulopathy.
Journal: Current opinion in anaesthesiology20100601
Title: Rivaroxaban for thromboprophylaxis in patients undergoing major orthopedic surgery.
Journal: The Annals of pharmacotherapy20100601
Title: Rivaroxaban for thromboembolism prophylaxis after orthopaedic surgery.
Journal: Anaesthesia20100601
Title: Drug and dietary interactions of the new and emerging oral anticoagulants.
Journal: International journal of clinical practice20100601
Title: Novel oral anticoagulants. Part II: direct thrombin inhibitors.
Journal: Expert review of hematology20100601
Title: [New oral anticoagulants: prospects].
Journal: La Revue du praticien20100520
Title: Emerging anticoagulants for venous thromboembolism prevention.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20100515
Title: New anticoagulants for prevention and treatment of venous thromboembolism.
Journal: Current vascular pharmacology20100501
Title: Rivaroxaban and dabigatran etexilate: two new oral anticoagulants for extended postoperative prevention of venous thromboembolism after elective total hip arthroplasty.
Journal: Archives of orthopaedic and trauma surgery20100501
Title: New and emerging antiarrhythmic and anticoagulant agents for atrial fibrillation.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20100501
Title: Primary prevention of venous thromboembolism in medical and surgical oncology patients.
Journal: British journal of cancer20100413
Title: Assessment of laboratory assays to measure rivaroxaban--an oral, direct factor Xa inhibitor.
Journal: Thrombosis and haemostasis20100401
Title: Facts and artefacts of coagulation assays for factor Xa inhibitors.
Journal: Thrombosis and haemostasis20100401
Title: Antithrombotic treatment failures in antiphospholipid syndrome: the new anticoagulants?
Journal: Lupus20100401
Title: Rivaroxaban vs dabigatran for thromboprophylaxis after joint-replacement surgery: exploratory indirect comparison based on meta-analysis of pivotal clinical trials.
Journal: Croatian medical journal20100401
Title: VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
Journal: Thrombosis research20100401
Title: Potential of new anticoagulants in patients with cancer.
Journal: Thrombosis research20100401
Title: Novel oral anticoagulants for prophylaxis and treatment of venous thromboembolism: part I (Factor Xa inhibitors).
Journal: Expert review of hematology20100401
Title: Comparative efficacy and safety of the novel oral anticoagulants dabigatran, rivaroxaban and apixaban in preclinical and clinical development.
Journal: Thrombosis and haemostasis20100301
Title: DVT: a new era in anticoagulant therapy.
Journal: Arteriosclerosis, thrombosis, and vascular biology20100301
Title: Rivaroxaban: a new oral factor Xa inhibitor.
Journal: Arteriosclerosis, thrombosis, and vascular biology20100301
Title: Antithrombotic drugs for patients with ischaemic stroke and transient ischaemic attack to prevent recurrent major vascular events.
Journal: The Lancet. Neurology20100301
Title: Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study.
Journal: American heart journal20100301
Title: Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.
Journal: The Journal of bone and joint surgery. British volume20100301
Title: Recent advances in the management of venous thromboembolism.
Journal: The Korean journal of hematology20100301
Title: New oral anticoagulants: a practical guide for clinicians.
Journal: Journal of thrombosis and thrombolysis20100201
Title: The ultimate anticoagulants?
Journal: Cardiovascular journal of Africa20100201
Title: [Update on new antithrombotic treatments].
Journal: Revue medicale suisse20100120
Title: The new oral anticoagulants.
Journal: Blood20100107
Title: Factor Xa inhibitors in acute coronary syndromes and venous thromboembolism.
Journal: Current vascular pharmacology20100101
Title: Safety, pharmacokinetics and pharmacodynamics of single doses of rivaroxaban - an oral, direct factor Xa inhibitor - in elderly Chinese subjects.
Journal: Thrombosis and haemostasis20100101
Title: The potential benefits of low-molecular-weight heparins in cancer patients.
Journal: Journal of hematology & oncology20100101
Title: [Prophylaxis of venous thromboembolism in orthopaedic surgery--trivial option, huge potential].
Journal: Zeitschrift fur Orthopadie und Unfallchirurgie20100101
Title: Entering the era of non-basic p1 site groups: discovery of Xarelto (Rivaroxaban).
Journal: Current topics in medicinal chemistry20100101
Title: New oral anticoagulants in development: potential for improved safety profiles.
Journal: Reviews in neurological diseases20100101
Title: Forecasting drug utilization and expenditure in a metropolitan health region.
Journal: BMC health services research20100101
Title: New options with dabigatran etexilate in anticoagulant therapy.
Journal: Vascular health and risk management20100101
Title: New anticoagulants for the prevention of venous thromboembolism.
Journal: Drug design, development and therapy20100101
Title: Deep vein thrombosis and pulmonary embolism - Prevention, management, and anaesthetic considerations.
Journal: Indian journal of anaesthesia20100101
Title: Novel anticoagulant therapy: principle and practice.
Journal: Methods in molecular biology (Clifton, N.J.)20100101
Title: Oral direct factor Xa inhibitors, with special emphasis on rivaroxaban.
Journal: Methods in molecular biology (Clifton, N.J.)20100101
Title: [Anticoagulant therapy in cardiology: yesterday, today, tomorrow].
Journal: Kardiologiia20100101
Title: Prevention strategies for cardioembolic stroke: present and future perspectives.
Journal: The open neurology journal20100101
Title: Oral anticoagulants in pediatric cardiac practice: A systematic review of the literature.
Journal: Annals of pediatric cardiology20100101
Title: Cost effectiveness of venous thromboembolism pharmacological prophylaxis in total hip and knee replacement: a systematic review.
Journal: PharmacoEconomics20100101
Title: Further issues with new oral anticoagulants.
Journal: Current pharmaceutical design20100101
Title: New anticoagulants for the prevention of thromboembolism.
Journal: Current pharmaceutical design20100101
Title: Pharmacologic properties of the new oral anticoagulants: a clinician-oriented review with a focus on perioperative management.
Journal: Current pharmaceutical design20100101
Title: Managing bleeding complications in patients treated with the old and the new anticoagulants.
Journal: Current pharmaceutical design20100101
Title: Post-operative thromboprophylaxis: new oral thrombin and factor X inhibitors and their place in clinical practice.
Journal: F1000 medicine reports20100101
Title: Effective single-drug approach is welcomed for deep-vein thrombosis treatment.
Journal: Cardiovascular journal of Africa20100101
Title: Rivaroxaban equals warfarin treatment in atrial fibrillation patients at high risk of stroke.
Journal: Cardiovascular journal of Africa20100101
Title: Development of new anticoagulant highly honoured: Bayer's Xarelto recognised with 2010 international Prix Galien award.
Journal: Cardiovascular journal of Africa20100101
Title: Newer antithrombotic drugs.
Journal: Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine20100101
Title: Simplifying thromboprophylaxis could improve outcomes in orthopaedic surgery.
Journal: Thrombosis20100101
Title: New oral anticoagulants for thromboprophylaxis after elective total hip and knee arthroplasty.
Journal: Thrombosis20100101
Title: Emerging antithrombotic agents for thromboprophylaxis, clinical potential and patient considerations.
Journal: Journal of blood medicine20100101
Title: Dabigatran or rivaroxaban versus other anticoagulants for thromboprophylaxis after major orthopedic surgery: systematic review of comparative clinical-effectiveness and safety.
Journal: CADTH technology overviews20100101
Title: Rivaroxaban in orthopedic surgery--a change of paradigm?
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis20091201
Title: Oral factor Xa inhibitors for thromboprophylaxis in major orthopedic surgery: a review.
Journal: Internal and emergency medicine20091201
Title: Will oral rivaroxaban improve clinically relevant outcomes and thromboprophylaxis management in the orthopedic patient?
Journal: Journal of thrombosis and haemostasis : JTH20091201
Title: [New oral anticoagulants. Consequences for perioperative coagulation diagnostics and therapy].
Journal: Der Anaesthesist20091201
Title: Rivaroxaban, the first oral, direct factor Xa inhibitor.
Journal: Expert opinion on pharmacotherapy20091201
Title: Oral anticoagulation with Factor Xa and thrombin inhibitors: Is there an alternative to warfarin?
Journal: Discovery medicine20091201
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20091201
Title: Heparin-induced thrombocytopaenia/thrombosis: a clinicopathologic review.
Journal: East African medical journal20091201
Title: Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
Journal: Thrombosis and haemostasis20091101
Title: Thromboprophylaxis after multiple trauma: what treatment and for how long?
Journal: Injury20091101
Title: [Pregnancy and venous thromboembolism. North-American and European guidelines. American College of Chest Physicians].
Journal: Journal des maladies vasculaires20091101
Title: New agents for orthopaedic thromboprophylaxis: caution essential, but time will tell.
Journal: ANZ journal of surgery20091101
Title: New antithrombotic drugs: potential for use in oncology.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology20091010
Title: Underestimation of the effect of bleeding in clinical trials.
Journal: Lancet (London, England)20091003
Title: New anticoagulants and regional anesthesia.
Journal: Current opinion in anaesthesiology20091001
Title: Anticoagulation with {blacktriangledown}dabigatran or{blacktriangledown}rivaroxaban.
Journal: Drug and therapeutics bulletin20091001
Title: Rivaroxaban for the prevention of venous thromboembolism: a single technology appraisal.
Journal: Health technology assessment (Winchester, England)20091001
Title: [Rivaroxaban (Xarelto): new anticoagulant inhibitor of factor Xa].
Journal: Revue medicale de Liege20091001
Title: Oral anticoagulation with factor Xa and thrombin inhibitors: on the threshold of change.
Journal: Current opinion in hematology20090901
Title: A logical approach to surgical thromboprophylaxis.
Journal: Current opinion in hematology20090901
Title: [Orthopedic patients with or without thrombophilia. Diagnostic, therapy and peri-operative strategies].
Journal: Der Orthopade20090901
Title: [New developments in antithrombotic care].
Journal: Revue medicale de Bruxelles20090901
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20090901
Title: Rivaroxaban versus enoxaparin after total knee arthroplasty.
Journal: Lancet (London, England)20090829
Title: Rivaroxaban versus enoxaparin after total knee arthroplasty.
Journal: Lancet (London, England)20090829
Title: Rivaroxaban versus enoxaparin after total knee arthroplasty.
Journal: Lancet (London, England)20090829
Title: Rivaroxaban versus enoxaparin after total knee arthroplasty.
Journal: Lancet (London, England)20090829
Title: Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits.
Journal: Journal of thrombosis and haemostasis : JTH20090801
Title: Recent developments in the use of oral anticoagulants.
Journal: Expert opinion on pharmacotherapy20090801
Title: Novel anticoagulants in clinical development: focus on factor Xa and direct thrombin inhibitors.
Journal: Journal of cardiovascular medicine (Hagerstown, Md.)20090801
Title: Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations.
Journal: Annals of surgery20090801
Title: Factor Xa inhibitors--new anticoagulants for secondary haemostasis.
Journal: Hamostaseologie20090801
Title: [Patients with oral anticoagulation--bridging anticoagulation in the perioperative phase].
Journal: Hamostaseologie20090801
Title: Rivaroxaban: new drug. After hip or knee replacement surgery: LMWH is safer.
Journal: Prescrire international20090801
Title: Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS-TIMI 46): a randomised, double-blind, phase II trial.
Journal: Lancet (London, England)20090704
Title: Rivaroxaban in acute coronary syndromes: too soon to know?
Journal: Lancet (London, England)20090704
Title: New anticoagulants: focus on venous thromboembolism.
Journal: Current vascular pharmacology20090701
Title: Safety, pharmacokinetics and pharmacodynamics of single/multiple doses of the oral, direct Factor Xa inhibitor rivaroxaban in healthy Chinese subjects.
Journal: British journal of clinical pharmacology20090701
Title: New anticoagulants for atrial fibrillation.
Journal: Seminars in thrombosis and hemostasis20090701
Title: [New agents for the prevention of venous thromboembolism].
Journal: Der Internist20090601
Title: Rivaroxaban for the prevention of venous thromboembolism following major orthopedic surgery: the RECORD trials.
Journal: Expert review of cardiovascular therapy20090601
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20090601
Title: 3-(3-Chloro-anilino)-1-(3,5-dimethyl-1H-pyrazol-1-yl)propan-1-one.
Journal: Acta crystallographica. Section E, Structure reports online20090601
Title: Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4): a randomised trial.
Journal: Lancet (London, England)20090516
Title: The importance of VTE prevention after orthopaedic surgery.
Journal: Lancet (London, England)20090516
Title: Rivaroxaban -- an oral, direct Factor Xa inhibitor: lessons from a broad clinical study programme.
Journal: European journal of haematology20090501
Title: Metabolism and excretion of rivaroxaban, an oral, direct factor Xa inhibitor, in rats, dogs, and humans.
Journal: Drug metabolism and disposition: the biological fate of chemicals20090501
Title: In vitro metabolism of rivaroxaban, an oral, direct factor Xa inhibitor, in liver microsomes and hepatocytes of rats, dogs, and humans.
Journal: Drug metabolism and disposition: the biological fate of chemicals20090501
Title: Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement.
Journal: The Journal of bone and joint surgery. British volume20090501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20090501
Title: Rivaroxaban (xarelto) for the prevention of thromboembolic disease: an inside look at the oral direct factor xa inhibitor.
Journal: P & T : a peer-reviewed journal for formulary management20090501
Title: [The new oral anticoagulant in the Netherlands].
Journal: Nederlands tijdschrift voor geneeskunde20090418
Title: Discovery of betrixaban (PRT054021), N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide, a highly potent, selective, and orally efficacious factor Xa inhibitor.
Journal: Bioorganic & medicinal chemistry letters20090415
Title: The direct factor Xa inhibitor rivaroxaban.
Journal: The Medical journal of Australia20090406
Title: Rivaroxaban, a new, oral, direct factor Xa inhibitor for thromboprophylaxis after major joint arthroplasty.
Journal: Expert opinion on pharmacotherapy20090401
Title: [New anticoagulants].
Journal: Deutsche medizinische Wochenschrift (1946)20090401
Title: Should new oral anticoagulants replace low-molecular-weight heparin for thromboprophylaxis in orthopaedic surgery?
Journal: Archives of cardiovascular diseases20090401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20090401
Title: [Venous thromboembolism prophylaxis in orthopaedics and traumatology].
Journal: Vnitrni lekarstvi20090301
Title: [Advances in antithrombotic treatment--antithrombotics with anti-Xa effect].
Journal: Vnitrni lekarstvi20090301
Title: The novel anticoagulants: entering a new era.
Journal: Swiss medical weekly20090207
Title: [The new antithrombotics in 2009].
Journal: Revue medicale suisse20090204
Title: Rivaroxaban: a novel, oral, direct factor Xa inhibitor.
Journal: Pharmacotherapy20090201
Title: New anticoagulants - towards the development of an 'ideal' anticoagulant.
Journal: VASA. Zeitschrift fur Gefasskrankheiten20090201
Title: Laboratory monitoring of anticoagulation: where do we stand?
Journal: Seminars in thrombosis and hemostasis20090201
Title: Comparative pharmacodynamics and pharmacokinetics of oral direct thrombin and factor xa inhibitors in development.
Journal: Clinical pharmacokinetics20090101
Title: Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q).
Journal: Health and quality of life outcomes20090101
Title: In the pipeline: new oral anticoagulants for the prevention of venous thromboembolism.
Journal: Orthopedics20090101
Title: New oral anticoagulants: not quite there yet.
Journal: Polskie Archiwum Medycyny Wewnetrznej20090101
Title: Old and new anticoagulant agents for the prevention and treatment of patients with ischemic stroke.
Journal: Cerebrovascular diseases (Basel, Switzerland)20090101
Title: Use of anticoagulants in elderly patients: practical recommendations.
Journal: Clinical interventions in aging20090101
Title: Rivaroxaban: an oral direct factor Xa inhibitor for the prevention of thromboembolism.
Journal: Cardiology in review20090101
Title: Interpretation of benefit-risk of enoxaparin as comparator in the RECORD program: rivaroxaban oral tablets (10 milligrams) for use in prophylaxis in deep vein thrombosis and pulmonary embolism in patients undergoing hip or knee replacement surgery.
Journal: Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis20090101
Title: Selecting the optimal antithrombotic regimen for patients with acute coronary syndromes undergoing percutaneous coronary intervention.
Journal: Vascular health and risk management20090101
Title: The prevention and treatment of venous thromboembolism with LMWHs and new anticoagulants.
Journal: Vascular health and risk management20090101
Title: [Dabigatran and rivaroxaban, new oral anticoagulants for the treatment of venous thromboembolism].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria20090101
Title: [Pharmacokinetics and pharmacodynamics of the new oral anticoagulants dabigatran and rivaroxaban].
Journal: Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria20090101
Title: Rivaroxaban: a review of its use for the prevention of venous thromboembolism after total hip or knee replacement surgery.
Journal: Drugs20090101
Title: [From old to new anticoagulants: the role of the biologist].
Journal: Annales de biologie clinique20090101
Title: New anticoagulants for the prevention of deep venous thrombosis: time to consider cost effectiveness?
Journal: PharmacoEconomics20090101
Title: A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the irish healthcare setting.
Journal: PharmacoEconomics20090101
Title: Prevention and treatment of thromboembolic events in medical patients and new anticoagulants.
Journal: Acta clinica Belgica20090101
Title: [Pharmacology of heparins and direct anticoagulants].
Journal: Hamostaseologie20081201
Title: [Rivaroxaban: a decisive step forward in the management of postoperative thromboembolic disease?].
Journal: Annales francaises d'anesthesie et de reanimation20081201
Title: [Rivaroxaban: clinical pharmacology].
Journal: Annales francaises d'anesthesie et de reanimation20081201
Title: [Perioperative venous thromboembolism prophylaxis: short review and recommendations].
Journal: Annales francaises d'anesthesie et de reanimation20081201
Title: [Rivaroxaban (Xarelto): efficacy and safety].
Journal: Annales francaises d'anesthesie et de reanimation20081201
Title: [Summary and perspectives. Rivaroxaban].
Journal: Annales francaises d'anesthesie et de reanimation20081201
Title: [Rivaroxaban: mode of action].
Journal: Annales francaises d'anesthesie et de reanimation20081201
Title: Emergence of new oral antithrombotics: a critical appraisal of their clinical potential.
Journal: Vascular health and risk management20081201
Title: Rivaroxaban for thromboprophylaxis.
Journal: The New England journal of medicine20081113
Title: Rivaroxaban for thromboprophylaxis.
Journal: The New England journal of medicine20081113
Title: Rivaroxaban for thromboprophylaxis.
Journal: The New England journal of medicine20081113
Title: Rivaroxaban for thromboprophylaxis.
Journal: The New England journal of medicine20081113
Title: [Rivaroxaban. The first factor Xa inhibitor].
Journal: Medizinische Monatsschrift fur Pharmazeuten20081101
Title: [Thromboembolic disease in orthopedic surgery].
Journal: Medicina clinica20081101
Title: [Anaesthesia and thromboembolic disease].
Journal: Medicina clinica20081101
Title: [New oral anticoagulants: molecular characteristics, mechanisms of action, pharmacokinetics and pharmacodynamics].
Journal: Medicina clinica20081101
Title: Polyphosphate as a general procoagulant agent.
Journal: Journal of thrombosis and haemostasis : JTH20081001
Title: Rivaroxaban--an oral, direct Factor Xa inhibitor--has potential for the management of patients with heparin-induced thrombocytopenia.
Journal: British journal of haematology20081001
Title: Differences in urinary prothrombin fragment 1 + 2 levels after total hip replacement in relation to venous thromboembolism and bleeding events.
Journal: Journal of thrombosis and haemostasis : JTH20081001
Title: Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects.
Journal: Current medical research and opinion20081001
Title: [Anticoagulation in atrial fibrillation].
Journal: Hamostaseologie20081001
Title: [Prophylaxis of venous thromboembolism].
Journal: Hamostaseologie20081001
Title: Rivaroxaban: future in anticoagulation practice?
Journal: Hematology (Amsterdam, Netherlands)20081001
Title: More effective, simpler-to-use clot-buster is on the way. Clot-prevention drug could save lives after joint replacement.
Journal: DukeMedicine healthnews20081001
Title: [Always more amputations in Germany?].
Journal: Deutsche medizinische Wochenschrift (1946)20081001
Title: Orally administered factor xa inhibitor, rivaroxaban: a novel thromboembolic prophylaxis agent.
Journal: Neurosurgery20081001
Title: A dose-ranging study evaluating once-daily oral administration of the factor Xa inhibitor rivaroxaban in the treatment of patients with acute symptomatic deep vein thrombosis: the Einstein-DVT Dose-Ranging Study.
Journal: Blood20080915
Title: Determination of rivaroxaban--a novel, oral, direct Factor Xa inhibitor--in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences20080901
Title: Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement.
Journal: Thrombosis and haemostasis20080901
Title: New developments in anticoagulation for atrial fibrillation.
Journal: Current treatment options in cardiovascular medicine20080901
Title: Rivaroxaban: an oral direct inhibitor of factor Xa.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists20080815
Title: Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
Journal: Clinical orthopaedics and related research20080801
Title: New compounds in the management of venous thromboembolism after orthopedic surgery: focus on rivaroxaban.
Journal: Vascular health and risk management20080801
Title: Extended duration rivaroxaban versus short-term enoxaparin for the prevention of venous thromboembolism after total hip arthroplasty: a double-blind, randomised controlled trial.
Journal: Lancet (London, England)20080705
Title: Selective factor Xa inhibition for thromboprophylaxis.
Journal: Lancet (London, England)20080705
Title: Rivaroxaban versus enoxaparin for thromboprophylaxis after hip arthroplasty.
Journal: The New England journal of medicine20080626
Title: Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty.
Journal: The New England journal of medicine20080626
Title: New anticoagulants--the path from discovery to clinical practice.
Journal: The New England journal of medicine20080626
Title: Rivaroxaban, an oral direct factor Xa inhibitor.
Journal: Expert opinion on investigational drugs20080601
Title: [Hematology 2008].
Journal: Deutsche medizinische Wochenschrift (1946)20080601
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20080601
Title: Preventing venous thromboembolism through risk assessment approaches.
Journal: British journal of nursing (Mark Allen Publishing)20080601
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20080401
Title: Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty.
Journal: Clinical orthopaedics and related research20080301
Title: New anticoagulants for treatment of venous thromboembolism.
Journal: Arteriosclerosis, thrombosis, and vascular biology20080301
Title: Update on atrial fibrillation: part I.
Journal: Clinical cardiology20080201
Title: [New anticoagulants].
Journal: Hamostaseologie20080201
Title: Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa.
Journal: Seminars in thrombosis and hemostasis20080201
Title: The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update.
Journal: Seminars in thrombosis and hemostasis20080201
Title: Randomized, double-blind, crossover study to investigate the effect of rivaroxaban on QT-interval prolongation.
Journal: Drug safety20080101
Title: New oral anticoagulants in atrial fibrillation.
Journal: European heart journal20080101
Title: Population pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor Xa inhibitor--in patients undergoing major orthopaedic surgery.
Journal: Clinical pharmacokinetics20080101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20080101
Title: Pharmacological strategies for inhibition of thrombin activity.
Journal: Current pharmaceutical design20080101
Title: The top 4 advances in antithrombotic care in the last year.
Journal: Thrombosis research20080101
Title: Brave new world: the current and future use of novel anticoagulants.
Journal: Thrombosis research20080101
Title: Thromboprophylaxis with rivaroxaban or enoxaparin did not differ for major bleeding or other safety outcomes in hip arthroplasty.
Journal: ACP journal club20080101
Title: Thromboprophylaxis with rivaroxaban or enoxaparin did not differ for major bleeding in knee arthroplasty.
Journal: ACP journal club20080101
Title: Controversies in the antiphospholipid syndrome: can we ever stop warfarin?
Journal: Journal of autoimmune diseases20080101
Title: New issues in oral anticoagulants.
Journal: Hematology. American Society of Hematology. Education Program20080101
Title: Oral factor Xa inhibitors for venous thromboembolism prevention in major orthopedic surgery: a review.
Journal: Pathophysiology of haemostasis and thrombosis20080101
Title: Effects of the oral, direct factor xa inhibitor rivaroxaban on platelet-induced thrombin generation and prothrombinase activity.
Journal: Journal of clinical pharmacology20071101
Title: Development of oral anticoagulants.
Journal: British journal of clinical pharmacology20070901
Title: Rivaroxaban. A novel, oral, direct factor Xa inhibitor in clinical development for the prevention and treatment of thromboembolic disorders.
Journal: Hamostaseologie20070901
Title: Beyond unfractionated heparin and warfarin: current and future advances.
Journal: Circulation20070731
Title: A replacement for warfarin: the search continues.
Journal: Circulation20070710
Title: Treatment of proximal deep-vein thrombosis with the oral direct factor Xa inhibitor rivaroxaban (BAY 59-7939): the ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients With Acute Symptomatic Deep-Vein Thrombosis) study.
Journal: Circulation20070710
Title: Ultrasound screening for asymptomatic deep vein thrombosis after major orthopaedic surgery: the VENUS study.
Journal: Journal of thrombosis and haemostasis : JTH20070701
Title: Preclinical and clinical characteristics of rivaroxaban: a novel, oral, direct factor Xa inhibitor.
Journal: Seminars in thrombosis and hemostasis20070701
Title: Oral, direct factor Xa inhibitors in development for the prevention and treatment of thromboembolic diseases.
Journal: Arteriosclerosis, thrombosis, and vascular biology20070601
Title: Rivaroxaban for thromboprophylaxis after orthopaedic surgery: pooled analysis of two studies.
Journal: Thrombosis and haemostasis20070601
Title: Population model of the pharmacokinetics and pharmacodynamics of rivaroxaban--an oral, direct factor xa inhibitor--in healthy subjects.
Journal: International journal of clinical pharmacology and therapeutics20070601
Title: Rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--has no clinically relevant interaction with naproxen.
Journal: British journal of clinical pharmacology20070401
Title: Investigational treatments of venous thromboembolism.
Journal: Expert opinion on investigational drugs20070401
Title: In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban.
Journal: Journal of thrombosis and haemostasis : JTH20070401
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20070401
Title: Prevention and treatment of experimental thrombosis in rabbits with rivaroxaban (BAY 597939)--an oral, direct factor Xa inhibitor.
Journal: Thrombosis and haemostasis20070301
Title: Rivaroxaban.
Journal: Drugs of today (Barcelona, Spain : 1998)20070301
Title: [New antitoagulants].
Journal: Annales pharmaceutiques francaises20070301
Title: Drug evaluation: rivaroxaban, an oral, direct inhibitor of activated factor X.
Journal: Current opinion in investigational drugs (London, England : 2000)20070301
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20070301
Title: Body weight has limited influence on the safety, tolerability, pharmacokinetics, or pharmacodynamics of rivaroxaban (BAY 59-7939) in healthy subjects.
Journal: Journal of clinical pharmacology20070201
Title: Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.
Journal: Thrombosis research20070101
Title: Stroke in atrial fibrillation: update on pathophysiology, new antithrombotic therapies, and evolution of procedures and devices.
Journal: Annals of medicine20070101
Title: Anithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy.
Journal: Thrombosis journal20070101
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20070101
Title: A once-daily, oral, direct Factor Xa inhibitor, rivaroxaban (BAY 59-7939), for thromboprophylaxis after total hip replacement.
Journal: Circulation20061128
Title: The scientific community's quest to identify optimal targets for anticoagulant pharmacotherapy.
Journal: Circulation20061128
Title: Safety, tolerability, pharmacodynamics, and pharmacokinetics of rivaroxaban--an oral, direct factor Xa inhibitor--are not affected by aspirin.
Journal: Journal of clinical pharmacology20060901
Title: Novel factor Xa inhibitors for prevention and treatment of thromboembolic diseases.
Journal: Expert opinion on investigational drugs20060801
Title: Effect of food, an antacid, and the H2 antagonist ranitidine on the absorption of BAY 59-7939 (rivaroxaban), an oral, direct factor Xa inhibitor, in healthy subjects.
Journal: Journal of clinical pharmacology20060501
Title: [Haemostasis and antithrombotic drugs: pharmacology and novel therapeutic approaches].
Journal: Hamostaseologie20060501
Title: Gateways to clinical trials.
Journal: Methods and findings in experimental and clinical pharmacology20060401
Title: New oral anticoagulants show promise.
Journal: JAMA20060215
Title: Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement.
Journal: Journal of thrombosis and haemostasis : JTH20060101
Title: Safety, pharmacodynamics, and pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--after multiple dosing in healthy male subjects.
Journal: European journal of clinical pharmacology20051201
Title: BAY 59-7939: an oral, direct factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study.
Journal: Journal of thrombosis and haemostasis : JTH20051101
Title: Safety, pharmacodynamics, and pharmacokinetics of single doses of BAY 59-7939, an oral, direct factor Xa inhibitor.
Journal: Clinical pharmacology and therapeutics20051001
Title: Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- [4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor.
Journal: Journal of medicinal chemistry20050922
Title: Pharmacokinetics of BAY 59-7939--an oral, direct Factor Xa inhibitor--in rats and dogs.
Journal: Xenobiotica; the fate of foreign compounds in biological systems20050901
Title: New antithrombotics in the prevention of thromboembolic disease.
Journal: European journal of internal medicine20050801
Title: In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor.
Journal: Journal of thrombosis and haemostasis : JTH20050301
Title: Roehrig S, et al. Discovery of the novel antithrombotic agent 5-chloro-N-({(5S)-2-oxo-3- -(3-oxomorpholin-4-yl)phenyl-1,3-oxazolidin-5-yl}methyl)thiophene- 2-carboxamide (BAY 59-7939): an oral, direct factor Xa inhibitor. J Med Chem. 2005 Sep 22;48(19)
Title: Perzborn E, et al. In vitro and in vivo studies of the novel antithrombotic agent BAY 59-7939--an oral, direct Factor Xa inhibitor. J Thromb Haemost. 2005 Mar;3(3):514-21.
